Vol. XVIII · Free shipping $75+ · Read the collection
Feature · Product Review
glutathione synthesis inhibitor

glutathione synthesis inhibitor Combined inhibition of de novo

Combined inhibition of de novo glutathione and nucleotide biosynthesis is synthetically lethal in glioblastoma ScienceDirect The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Blood Cancer Journal Frontiers The versatile utility of cysteine as a target for cancer treatment Buthionine sulfoximine, an inhibitor of glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: Roles of the NF B and MAPK signaling pathways

SKU: 50264547826 · From cantondelareina.com.ar

4.5
USD29.16 USD58.16

Pay in 4 interest-free payments of $7.29 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Aug 12 - Aug 17

Description

incomplete clinical data

glutathione synthesis inhibitor Combined inhibition of de novo

In an assay of neurotrophic activity, Dihexa was found to be seven orders of magnitude more potent than brain-derived neurotrophic factor

glutathione synthesis inhibitor Combined inhibition of de novo

"The latest therapeutic strategies after resistance to first generation epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) in patients with non-small cell lung cancer (NSCLC)"

glutathione synthesis inhibitor Combined inhibition of de novo

& Bauman, J

glutathione synthesis inhibitor Combined inhibition of de novo
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products